Anti-SLC17A8 monoclonal antibody

Pre-made anti-SLC17A8 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to SLC17A8/SLC17A8 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1655-Ab-1/ GM-Tg-hg-IP1655-Ab-2Anti-Human SLC17A8 monoclonal antibodyHuman
GM-Tg-rg-IP1655-Ab-1/ GM-Tg-rg-IP1655-Ab-2Anti-Rat SLC17A8 monoclonal antibodyRat
GM-Tg-mg-IP1655-Ab-1/ GM-Tg-mg-IP1655-Ab-2Anti-Mouse SLC17A8 monoclonal antibodyMouse
GM-Tg-cynog-IP1655-Ab-1/ GM-Tg-cynog-IP1655-Ab-2Anti-Cynomolgus/ Rhesus macaque SLC17A8 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1655-Ab-1/ GM-Tg-felg-IP1655-Ab-2Anti-Feline SLC17A8 monoclonal antibodyFeline
GM-Tg-cang-IP1655-Ab-1/ GM-Tg-cang-IP1655-Ab-2Anti-Canine SLC17A8 monoclonal antibodyCanine
GM-Tg-bovg-IP1655-Ab-1/ GM-Tg-bovg-IP1655-Ab-2Anti-Bovine SLC17A8 monoclonal antibodyBovine
GM-Tg-equg-IP1655-Ab-1/ GM-Tg-equg-IP1655-Ab-2Anti-Equine SLC17A8 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1655-Ab-1/ GM-Tg-hg-IP1655-Ab-2; GM-Tg-rg-IP1655-Ab-1/ GM-Tg-rg-IP1655-Ab-2;
GM-Tg-mg-IP1655-Ab-1/ GM-Tg-mg-IP1655-Ab-2; GM-Tg-cynog-IP1655-Ab-1/ GM-Tg-cynog-IP1655-Ab-2;
GM-Tg-felg-IP1655-Ab-1/ GM-Tg-felg-IP1655-Ab-2; GM-Tg-cang-IP1655-Ab-1/ GM-Tg-cang-IP1655-Ab-2;
GM-Tg-bovg-IP1655-Ab-1/ GM-Tg-bovg-IP1655-Ab-2; GM-Tg-equg-IP1655-Ab-1/ GM-Tg-equg-IP1655-Ab-2
Products NameAnti-SLC17A8 monoclonal antibody
Formatmab
Target NameSLC17A8
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-SLC17A8 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1655-Ag-1Recombinant multi-species VGLU3/ SLC17A8/ DFNA25 protein
    ORF Viral VectorpGMLPm004252mouse Slc17a8 Lentivirus plasmid
    ORF Viral VectorvGMLPm004252mouse Slc17a8 Lentivirus particle


    Target information

    Target IDGM-IP1655
    Target NameSLC17A8
    Gene ID246213,216227,266767,695508,482623,101096579,529659,100052766
    Gene Symbol and SynonymsDFNA25,SLC17A8,VGLUT3,Vgt3
    Uniprot AccessionQ8NDX2,Q7TSF2
    Uniprot Entry NameVGLU3_HUMAN,VGLU3_RAT
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000179520
    Target ClassificationN/A

    The target: SLC17A8, gene name: SLC17A8, also named as DFNA25, VGLUT3. This gene encodes a vesicular glutamate transporter. The encoded protein transports the neurotransmitter glutamate into synaptic vesicles before it is released into the synaptic cleft. Mutations in this gene are the cause of autosomal-dominant nonsyndromic type 25 deafness. Alternate splicing results in multiple transcript variants.[provided by RefSeq, May 2010].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.